S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

HealthEquity (HQY) Stock Forecast, Price & News

+1.82 (+2.98%)
(As of 05/27/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
412,835 shs
Average Volume
725,139 shs
Market Capitalization
$5.30 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HealthEquity logo

About HealthEquity

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.


See More Headlines

Industry, Sector and Symbol

Business services, not elsewhere classified
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$756.56 million
Cash Flow
$2.67 per share
Book Value
$22.16 per share


Net Income
$-44.29 million
Pretax Margin




Free Float
Market Cap
$5.30 billion

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End


Overall MarketRank

2.37 out of 5 stars

Medical Sector

100th out of 1,424 stocks

Business Services, Not Elsewhere Classified Industry

29th out of 141 stocks

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

HealthEquity (NASDAQ:HQY) Frequently Asked Questions

Is HealthEquity a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HealthEquity stock.
View analyst ratings for HealthEquity
or view top-rated stocks.

When is HealthEquity's next earnings date?

HealthEquity is scheduled to release its next quarterly earnings announcement on Monday, June 6th 2022.
View our earnings forecast for HealthEquity

How can I listen to HealthEquity's earnings call?

HealthEquity will be holding an earnings conference call on Monday, June 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 661-378-9636 with passcode "6370704".

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) announced its quarterly earnings data on Tuesday, March, 22nd. The company reported $0.09 EPS for the quarter, meeting analysts' consensus estimates of $0.09. The company earned $203.30 million during the quarter, compared to analyst estimates of $199.27 million. HealthEquity had a negative net margin of 5.85% and a positive trailing twelve-month return on equity of 3.49%. During the same quarter in the previous year, the company earned $0.30 earnings per share.
View HealthEquity's earnings history

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity issued an update on its FY 2023 earnings guidance on Tuesday, April, 19th. The company provided earnings per share guidance of $1.210-$1.300 for the period, compared to the consensus estimate of $1.410. The company issued revenue guidance of $820 million-$830 million, compared to the consensus revenue estimate of $817.41 million.

What price target have analysts set for HQY?

12 brokers have issued 1 year price objectives for HealthEquity's stock. Their forecasts range from $56.00 to $100.00. On average, they expect HealthEquity's stock price to reach $78.15 in the next twelve months. This suggests a possible upside of 24.4% from the stock's current price.
View analysts' price targets for HealthEquity
or view top-rated stocks among Wall Street analysts.

Who are HealthEquity's key executives?
HealthEquity's management team includes the following people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 54, Pay $1.39M)
  • Mr. Edward Bloomberg, Exec. VP & COO (Age 45, Pay $703.51k) (LinkedIn Profile)
  • Mr. Darcy G. Mott, Special Advisor (Age 69, Pay $700.98k)
  • Mr. Tyson Murdock, Exec. VP & CFO (Age 51)
  • Mr. Eli Rosner, Exec. VP & CTO
  • Mr. Richard Putnam, VP of Investor Relations
  • Mr. Delano Ladd, Exec. VP, Gen. Counsel & Sec. (Age 41)
  • Mr. Steve Lindsay, Exec. VP of Sales & Relationship Management
  • Mr. Brad Bennion, Sr. VP of Corp. Devel.
  • Ms. Tia Padia, Sr. VP of Marketing
What is Jon Kessler's approval rating as HealthEquity's CEO?

197 employees have rated HealthEquity CEO Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among HealthEquity's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Square (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.24%), Vanguard Group Inc. (9.54%), Wasatch Advisors Inc. (9.11%), William Blair Investment Management LLC (3.71%), JPMorgan Chase & Co. (3.18%) and State Street Corp (3.15%). Company insiders that own HealthEquity stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten.
View institutional ownership trends for HealthEquity

Which institutional investors are selling HealthEquity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Mackenzie Financial Corp, Eversept Partners LP, Royal Bank of Canada, Pier Capital LLC, PEAK6 Investments LLC, Motley Fool Asset Management LLC, and Peregrine Capital Management LLC. Company insiders that have sold HealthEquity company stock in the last year include Angelique Christine Hill, Darcy G Mott, Debra Charlotte Mccowan, Edward Bloomberg, Frank Corvino, Ian Sacks, and William Robert Otten.
View insider buying and selling activity for HealthEquity
or view top insider-selling stocks.

Which institutional investors are buying HealthEquity stock?

HQY stock was bought by a variety of institutional investors in the last quarter, including Van Berkom & Associates Inc., Granite Investment Partners LLC, BlackRock Inc., Nicholas Investment Partners LP, Wasatch Advisors Inc., Sectoral Asset Management Inc., TimesSquare Capital Management LLC, and Dimensional Fund Advisors LP. Company insiders that have bought HealthEquity stock in the last two years include Adrian T Dillon, and Stuart B Parker.
View insider buying and selling activity for HealthEquity
or or view top insider-buying stocks.

How do I buy shares of HealthEquity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HealthEquity's stock price today?

One share of HQY stock can currently be purchased for approximately $62.80.

How much money does HealthEquity make?

HealthEquity has a market capitalization of $5.30 billion and generates $756.56 million in revenue each year. The company earns $-44.29 million in net income (profit) each year or ($0.53) on an earnings per share basis.

How many employees does HealthEquity have?

HealthEquity employs 3,695 workers across the globe.

What is HealthEquity's official website?

The official website for HealthEquity is www.healthequity.com.

How can I contact HealthEquity?

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at (801) 727-1000, via email at [email protected], or via fax at 801-727-1005.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.